Outcome of hearing preservation related to tumor morphologic analysis in acoustic neuromas treated by gamma knife radiosurgery

Abstract

BackgroundGamma Knife radiosurgery (GKRS) is an important part of the neurosurgical armamentarium in the treatment of acoustic neuromas. However, the treatment outcome related to the morphology of the tumor has not been rigorously studied. In this cohort, we evaluated the morphological features of the tumor in the tumor response and neurological outcomes after GKRS.Material and methodsFrom July 2003 to December 2008, there were 93 cases of acoustic neuromas treated upfront with GKRS with 64 cases with serviceable hearing and 29 cases without serviceable hearing to fulfill the margin dose of 12Gy with at least follow up 5 years.ResultsThe duration of symptom before GKRS in serviceable /no serviceable hearing was 7.9 ± 1.2 and 15.3 ± 3.1 months (p < 0.001) and associated no-hearing symptom was 70% and 35%, respectively (p < 0.001). There was 81.2% of hearing preservation after GKRS in serviceable hearing group including 27 cases of pear type (84%), 14 of linear type (70%), and 9 cases of sphere type (90%) (p < 0.01); however, there was no case of hearing improvement in the no-serviceable hearing group (0 of 29). There were 85% of patients with decreased tinnitus in serviceable hearing groups as compared to 61.5% of patients in no serviceable hearing group (p < 0.05). In multivariate analysis, the tumor morphology was highly correlated to hearing preservation rate (p < 0.01).ConclusionIn the limited case of this cohort, we found that the tumor morphology and timing of treatment was highly correlated to the rate of hearing preservation. The sphere type of tumor morphology was associated with the best chance of hearing preservation.

Outcome of intracerebral cavernoma treated by Gamma Knife radiosurgery based on a double-blind assessment of treatment indication

“…If patients experienced new neurological deficits (increased seizure frequency, impairment sensory of motor function), they underwent additional imaging examinations at the time of newly neurological deficits to evaluate for radiologic changes associated with these clinical changes. The assessment of volume alteration was based on our previous investigation with volume enlargement by 20% defined as increase, volume reduction by 20% defined as decrease, and volume changes of less than 20% from baseline defined as stable [ 36 ].…”

The Effect of Cochlear Dose on Hearing Preservation After Low-Dose Stereotactic Radiosurgery for Vestibular Schwannomas: A Systematic Review

“…Three studies did not specify the cochlear dose parameter but instead referred to it simply as "cochlear dose". 29,34,35 Only a point dose at the modiolus was calculated in one study. 13 While most studies stated that volumetric cochlear dosimetry was performed, whether the maximum cochlear dose corresponded to a point or volume maximum was not always stated.…”

Hearing Preservation in Stereotactic Radiosurgery for Vestibular Schwannoma

“…8 While Pan and colleagues reported that 81.2% of patients maintained serviceable hearing with a dose of 12 Gy prescribed to the 50% isodose line, they found that cochlear and brainstem doses did not predict hearing outcomes. 33…”